UpToDate
Official reprint from UpToDate®
www.uptodate.com ©2017 UpToDate, Inc. and/or its affiliates. All Rights Reserved.

Overview of smoking cessation management in adults

Author
Nancy A Rigotti, MD
Section Editors
James K Stoller, MD, MS
Mark D Aronson, MD
Deputy Editor
Judith A Melin, MA, MD, FACP

INTRODUCTION

Cigarette smoking is the leading preventable cause of mortality. Smokers who quit smoking reduce their risk of developing and dying from tobacco-related diseases [1,2].

This topic provides an overview of smoking cessation management in adults, and a simple five-step algorithm called the “5 A’s” (Ask, Advise, Assess, Assist, Arrange) (table 1 and table 2) with suggestions for implementation in primary care practice.

Pharmacologic treatments and behavioral counseling to support smoking cessation, and the benefits of smoking cessation are discussed in more detail separately. (See "Pharmacotherapy for smoking cessation in adults" and "Behavioral approaches to smoking cessation" and "Benefits and risks of smoking cessation".)

Management of smoking cessation in adolescents and pregnant women is discussed separately. (See "Management of smoking cessation in adolescents" and "Cigarette smoking: Impact on pregnancy and the neonate", section on 'Smoking cessation'.)

EPIDEMIOLOGY

Approximately two-thirds of smokers say that they want to quit, and over 50 percent of smokers report that they tried to quit in the past year [3,4]. However, only 3 to 6 percent of smokers who make an unaided quit attempt are still abstinent one year later. Fewer than one-third of adult smokers who try to quit seek help, and even fewer use the most effective treatments [3-5]. With optimal treatment, 25 to 35 percent of smokers who try to quit can succeed for six months or more [6].

                                
To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information on subscription options, click below on the option that best describes you:

Subscribers log in here

Literature review current through: Nov 2017. | This topic last updated: Feb 17, 2017.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2017 UpToDate, Inc.
References
Top
  1. Anthonisen NR, Skeans MA, Wise RA, et al. The effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trial. Ann Intern Med 2005; 142:233.
  2. Jha P, Ramasundarahettige C, Landsman V, et al. 21st-century hazards of smoking and benefits of cessation in the United States. N Engl J Med 2013; 368:341.
  3. Rigotti NA. Strategies to help a smoker who is struggling to quit. JAMA 2012; 308:1573.
  4. Babb S, Malarcher A, Schauer G, et al. Quitting Smoking Among Adults - United States, 2000-2015. MMWR Morb Mortal Wkly Rep 2017; 65:1457.
  5. Behavioral and Pharmacotherapy Interventions for Tobacco Smoking Cessation in Adults, Including Pregnant Women: U.S. Preventive Services Task Force Recommendation Statement. Available at: http://annals.org/article.aspx?articleid=2443060 (Accessed on October 28, 2015).
  6. Anthenelli RM, Benowitz NL, West R, et al. Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial. Lancet 2016; 387:2507.
  7. Siu AL, U.S. Preventive Services Task Force. Behavioral and pharmacotherapy interventions for tobacco smoking cessation in adults, including pregnant women: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2015; 163:622.
  8. Lancaster T, Stead L. Physician advice for smoking cessation. Cochrane Database Syst Rev 2004; :CD000165.
  9. 2008 PHS Guideline Update Panel, Liaisons, and Staff. Treating tobacco use and dependence: 2008 update U.S. Public Health Service Clinical Practice Guideline executive summary. Respir Care 2008; 53:1217.
  10. Boyle RG, Solberg LI, Fiore MC. Electronic medical records to increase the clinical treatment of tobacco dependence: a systematic review. Am J Prev Med 2010; 39:S77.
  11. Park ER, Gareen IF, Japuntich S, et al. Primary Care Provider-Delivered Smoking Cessation Interventions and Smoking Cessation Among Participants in the National Lung Screening Trial. JAMA Intern Med 2015; 175:1509.
  12. West R. Assessment of dependence and motivation to stop smoking. BMJ 2004; 328:338.
  13. Heatherton TF, Kozlowski LT, Frecker RC, Fagerström KO. The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire. Br J Addict 1991; 86:1119.
  14. Kasza KA, Ambrose BK, Conway KP, et al. Tobacco-Product Use by Adults and Youths in the United States in 2013 and 2014. N Engl J Med 2017; 376:342.
  15. Smoking cessation: information for specialists. Agency for Health Care Policy and Research. Clin Pract Guidel Quick Ref Guide Clin 1996; :1.
  16. Stead LF, Buitrago D, Preciado N, et al. Physician advice for smoking cessation. Cochrane Database Syst Rev 2013; :CD000165.
  17. Solberg LI, Boyle RG, Davidson G, et al. Patient satisfaction and discussion of smoking cessation during clinical visits. Mayo Clin Proc 2001; 76:138.
  18. Barnfather KD, Cope GF, Chapple IL. Effect of incorporating a 10 minute point of care test for salivary nicotine metabolites into a general practice based smoking cessation programme: randomised controlled trial. BMJ 2005; 331:999.
  19. Parkes G, Greenhalgh T, Griffin M, Dent R. Effect on smoking quit rate of telling patients their lung age: the Step2quit randomised controlled trial. BMJ 2008; 336:598.
  20. Bize R, Burnand B, Mueller Y, et al. Biomedical risk assessment as an aid for smoking cessation. Cochrane Database Syst Rev 2009; :CD004705.
  21. Steinberg MB, Schmelzer AC, Richardson DL, Foulds J. The case for treating tobacco dependence as a chronic disease. Ann Intern Med 2008; 148:554.
  22. Kotz D, Wesseling G, Huibers MJ, van Schayck OC. Efficacy of confronting smokers with airflow limitation for smoking cessation. Eur Respir J 2009; 33:754.
  23. Coleman T. Near patient tests for smoking cessation. BMJ 2005; 331:979.
  24. DiClemente CC, Prochaska JO, Fairhurst SK, et al. The process of smoking cessation: an analysis of precontemplation, contemplation, and preparation stages of change. J Consult Clin Psychol 1991; 59:295.
  25. West R. Time for a change: putting the Transtheoretical (Stages of Change) Model to rest. Addiction 2005; 100:1036.
  26. Cahill K, Lancaster T, Green N. Stage-based interventions for smoking cessation. Cochrane Database Syst Rev 2010; :CD004492.
  27. Haas JS, Linder JA, Park ER, et al. Proactive tobacco cessation outreach to smokers of low socioeconomic status: a randomized clinical trial. JAMA Intern Med 2015; 175:218.
  28. Fu SS, van Ryn M, Sherman SE, et al. Proactive tobacco treatment and population-level cessation: a pragmatic randomized clinical trial. JAMA Intern Med 2014; 174:671.
  29. Aveyard P, Lindson-Hawley N, Hastings G, de Andrade M. Should smokers be advised to cut down as well as quit? BMJ 2014; 348:g2787.
  30. Lindson-Hawley N, Aveyard P, Hughes JR. Reduction versus abrupt cessation in smokers who want to quit. Cochrane Database Syst Rev 2012; 11:CD008033.
  31. Baha M, Le Faou AL. Gradual versus abrupt quitting among French treatment-seeking smokers. Prev Med 2014; 63:96.
  32. Lindson-Hawley N, Banting M, West R, et al. Gradual Versus Abrupt Smoking Cessation: A Randomized, Controlled Noninferiority Trial. Ann Intern Med 2016; 164:585.
  33. Henningfield JE, Miyasato K, Jasinski DR. Abuse liability and pharmacodynamic characteristics of intravenous and inhaled nicotine. J Pharmacol Exp Ther 1985; 234:1.
  34. Diagnostic and Statistical Manual of Mental Disorders, American Psychiatric Association, Washington, DC 1994.
  35. Suls JM, Luger TM, Curry SJ, et al. Efficacy of smoking-cessation interventions for young adults: a meta-analysis. Am J Prev Med 2012; 42:655.
  36. Stead LF, Koilpillai P, Lancaster T. Additional behavioural support as an adjunct to pharmacotherapy for smoking cessation. Cochrane Database Syst Rev 2015; :CD009670.
  37. Stead LF, Koilpillai P, Fanshawe TR, Lancaster T. Combined pharmacotherapy and behavioural interventions for smoking cessation. Cochrane Database Syst Rev 2016; 3:CD008286.
  38. McAfee T, Babb S, McNabb S, Fiore MC. Helping smokers quit--opportunities created by the Affordable Care Act. N Engl J Med 2015; 372:5.
  39. Kotz D, Brown J, West R. Prospective cohort study of the effectiveness of smoking cessation treatments used in the "real world". Mayo Clin Proc 2014; 89:1360.
  40. White AR, Rampes H, Liu JP, et al. Acupuncture and related interventions for smoking cessation. Cochrane Database Syst Rev 2011; :CD000009.
  41. Tahiri M, Mottillo S, Joseph L, et al. Alternative smoking cessation aids: a meta-analysis of randomized controlled trials. Am J Med 2012; 125:576.
  42. Barnes J, Dong CY, McRobbie H, et al. Hypnotherapy for smoking cessation. Cochrane Database Syst Rev 2010; :CD001008.
  43. Cahill K, Hartmann-Boyce J, Perera R. Incentives for smoking cessation. Cochrane Database Syst Rev 2015; :CD004307.
  44. Etter JF, Schmid F. Effects of Large Financial Incentives for Long-Term Smoking Cessation: A Randomized Trial. J Am Coll Cardiol 2016; 68:777.
  45. Volpp KG, Troxel AB, Pauly MV, et al. A randomized, controlled trial of financial incentives for smoking cessation. N Engl J Med 2009; 360:699.
  46. Halpern SD, French B, Small DS, et al. Randomized trial of four financial-incentive programs for smoking cessation. N Engl J Med 2015; 372:2108.
  47. Aveyard P, Bauld L. Incentives for promoting smoking cessation: What we still do not know. Cochrane Database Syst Rev 2011; :ED000027.
  48. Hughes JR, Solomon LJ, Naud S, et al. Natural history of attempts to stop smoking. Nicotine Tob Res 2014; 16:1190.
  49. Hajek P, Stead LF, West R, et al. Relapse prevention interventions for smoking cessation. Cochrane Database Syst Rev 2009; :CD003999.
  50. Stapleton JA, Sutherland G, Russell MA. How much does relapse after one year erode effectiveness of smoking cessation treatments? Long-term follow up of randomised trial of nicotine nasal spray. BMJ 1998; 316:830.
  51. Mikkelsen KL, Tønnesen P, Nørregaard J. Three-year outcome of two- and three-year sustained abstainers from a smoking cessation study with nicotine patches. J Smok Rel Dis 1994; 5:95.
  52. Anthonisen NR, Connett JE, Kiley JP, et al. Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study. JAMA 1994; 272:1497.
  53. Agboola S, McNeill A, Coleman T, Leonardi Bee J. A systematic review of the effectiveness of smoking relapse prevention interventions for abstinent smokers. Addiction 2010; 105:1362.
  54. Hajek P, Stead LF, West R, et al. Relapse prevention interventions for smoking cessation. Cochrane Database Syst Rev 2013; :CD003999.
  55. Fu SS, Partin MR, Snyder A, et al. Promoting repeat tobacco dependence treatment: are relapsed smokers interested? Am J Manag Care 2006; 12:235.
  56. Prochaska JJ. Smoking and mental illness--breaking the link. N Engl J Med 2011; 365:196.
  57. Cavazos-Rehg PA, Breslau N, Hatsukami D, et al. Smoking cessation is associated with lower rates of mood/anxiety and alcohol use disorders. Psychol Med 2014; 44:2523.
  58. Barth J, Jacob T, Daha I, Critchley JA. Psychosocial interventions for smoking cessation in patients with coronary heart disease. Cochrane Database Syst Rev 2015; :CD006886.
  59. Rigotti NA, Munafo MR, Stead LF. Smoking cessation interventions for hospitalized smokers: a systematic review. Arch Intern Med 2008; 168:1950.
  60. Keenan PS. Smoking and weight change after new health diagnoses in older adults. Arch Intern Med 2009; 169:237.
  61. Shi Y, Warner DO. Surgery as a teachable moment for smoking cessation. Anesthesiology 2010; 112:102.
  62. Rigotti NA, Clair C, Munafò MR, Stead LF. Interventions for smoking cessation in hospitalised patients. Cochrane Database Syst Rev 2012; :CD001837.
  63. Rigotti NA, Regan S, Levy DE, et al. Sustained care intervention and postdischarge smoking cessation among hospitalized adults: a randomized clinical trial. JAMA 2014; 312:719.
  64. Prescott E, Scharling H, Osler M, Schnohr P. Importance of light smoking and inhalation habits on risk of myocardial infarction and all cause mortality. A 22 year follow up of 12 149 men and women in The Copenhagen City Heart Study. J Epidemiol Community Health 2002; 56:702.
  65. Thomsen T, Villebro N, Møller AM. Interventions for preoperative smoking cessation. Cochrane Database Syst Rev 2014; :CD002294.
  66. Lee SM, Landry J, Jones PM, et al. Long-term quit rates after a perioperative smoking cessation randomized controlled trial. Anesth Analg 2015; 120:582.
  67. Ministry of Health. New Zealand Smoking Cessation Guidelines. Ministry of Health, Wellington 2007. Available at www.moh.govt.nz/moh.nsf/indexmh/nz-smoking-cessation-guidelines?Open. Accessed September 27, 2011.
  68. Schroeder SA. What to do with a patient who smokes. JAMA 2005; 294:482.
  69. Silfen SL, Farley SM, Shih SC, et al. Increases in smoking cessation interventions after a feedback and improvement initiative using electronic health records -- 19 community health centers, New York City, October 2010-March 2012. MMWR Morb Mortal Wkly Rep 2014; 63:921.
  70. Boyle R, Solberg L, Fiore M. Use of electronic health records to support smoking cessation. Cochrane Database Syst Rev 2014; :CD008743.
  71. Danan ER, Joseph AM, Sherman SE, et al. Does Motivation Matter? Analysis of a Randomized Trial of Proactive Outreach to VA Smokers. J Gen Intern Med 2016; 31:878.